An efficient and practical radiosynthesis of [11C]temozolomide

Christian K. Moseley; Stephen M. Carlin; Ramesh Neelamegam; Jacob M. Hooker

doi:10.1021/ol302791x

An efficient and practical radiosynthesis of [¹¹C]temozolomide

Christian K. Moseley, Stephen M. Carlin, Ramesh Neelamegam, Jacob M. Hooker

Research output: Contribution to journal › Article

13 Scopus citations

Abstract

Temozolomide (TMZ) is a prodrug for an alkylating agent used for the treatment of malignant brain tumors. A positron emitting version, [ ¹¹C]TMZ, has been utilized to help elucidate the mechanism and biodistribution of TMZ. Challenges in [¹¹C]TMZ synthesis and reformulation make it difficult for routine production. A highly reproducible one-pot radiosynthesis of [¹¹C]TMZ with a radiochemical yield of 17 ± 5% and ≥97% radiochemical purity is reported.

Original language	English (US)
Pages (from-to)	5872-5875
Number of pages	4
Journal	Organic Letters
Volume	14
Issue number	23
DOIs	https://doi.org/10.1021/ol302791x
State	Published - Dec 7 2012
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Physical and Theoretical Chemistry
Organic Chemistry

Access to Document

10.1021/ol302791x

Fingerprint Dive into the research topics of 'An efficient and practical radiosynthesis of [<sup>11</sup>C]temozolomide'. Together they form a unique fingerprint.

Cite this

Moseley, C. K., Carlin, S. M., Neelamegam, R., & Hooker, J. M. (2012). An efficient and practical radiosynthesis of [¹¹C]temozolomide. Organic Letters, 14(23), 5872-5875. https://doi.org/10.1021/ol302791x

@article{a610dcb5761d4ea6800e8c989f444aa2,

title = "An efficient and practical radiosynthesis of [11C]temozolomide",

abstract = "Temozolomide (TMZ) is a prodrug for an alkylating agent used for the treatment of malignant brain tumors. A positron emitting version, [ 11C]TMZ, has been utilized to help elucidate the mechanism and biodistribution of TMZ. Challenges in [11C]TMZ synthesis and reformulation make it difficult for routine production. A highly reproducible one-pot radiosynthesis of [11C]TMZ with a radiochemical yield of 17 ± 5% and ≥97% radiochemical purity is reported.",

author = "Moseley, {Christian K.} and Carlin, {Stephen M.} and Ramesh Neelamegam and Hooker, {Jacob M.}",

year = "2012",

month = dec,

day = "7",

doi = "10.1021/ol302791x",

language = "English (US)",

volume = "14",

pages = "5872--5875",

journal = "Organic Letters",

issn = "1523-7060",

publisher = "American Chemical Society",

number = "23",

}

TY - JOUR

T1 - An efficient and practical radiosynthesis of [11C]temozolomide

AU - Moseley, Christian K.

AU - Carlin, Stephen M.

AU - Neelamegam, Ramesh

AU - Hooker, Jacob M.

PY - 2012/12/7

Y1 - 2012/12/7

N2 - Temozolomide (TMZ) is a prodrug for an alkylating agent used for the treatment of malignant brain tumors. A positron emitting version, [ 11C]TMZ, has been utilized to help elucidate the mechanism and biodistribution of TMZ. Challenges in [11C]TMZ synthesis and reformulation make it difficult for routine production. A highly reproducible one-pot radiosynthesis of [11C]TMZ with a radiochemical yield of 17 ± 5% and ≥97% radiochemical purity is reported.

AB - Temozolomide (TMZ) is a prodrug for an alkylating agent used for the treatment of malignant brain tumors. A positron emitting version, [ 11C]TMZ, has been utilized to help elucidate the mechanism and biodistribution of TMZ. Challenges in [11C]TMZ synthesis and reformulation make it difficult for routine production. A highly reproducible one-pot radiosynthesis of [11C]TMZ with a radiochemical yield of 17 ± 5% and ≥97% radiochemical purity is reported.

UR - http://www.scopus.com/inward/record.url?scp=84870947124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870947124&partnerID=8YFLogxK

U2 - 10.1021/ol302791x

DO - 10.1021/ol302791x

M3 - Article

C2 - 23151019

AN - SCOPUS:84870947124

VL - 14

SP - 5872

EP - 5875

JO - Organic Letters

JF - Organic Letters

SN - 1523-7060

IS - 23

ER -